Venus Remedies informs about press release

01 Jun 2023 Evaluate

Venus Remedies has informed that it enclosed press release being issued by the Company today titled ‘Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Venus Remedies Share Price

703.80 2.70 (0.39%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×